BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 2411137)

  • 1. A study of the NB/7OK and CA 125 monoclonal antibody radioimmunoassays for measuring serum antigen levels in ovarian cancer patients.
    Knauf S; Anderson DJ; Knapp RC; Bast RC
    Am J Obstet Gynecol; 1985 Aug; 152(7 Pt 1):911-3. PubMed ID: 2411137
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor antigen NB/70K and CA 125 levels in the blood of preoperative ovarian cancer patients and controls: a preliminary report of the use of the NB12123 and CA 125 radioimmunoassays alone and in combination.
    Knauf S; Bast RC
    Int J Biol Markers; 1988; 3(2):75-81. PubMed ID: 3243980
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Monoclonal antibodies against human ovarian tumor associated antigen NB/70K: preparation and use in a radioimmunoassay for measuring NB/70K in serum.
    Knauf S; Kalwas J; Helmkamp BF; Harwell LW; Beecham J; Lord EM
    Cancer Immunol Immunother; 1986; 21(3):217-25. PubMed ID: 2421899
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A monoclonal antibody radioimmunoassay for an antigenic determinant CA125 in ovarian cancer patients.
    Lian LJ; Hu XF; Liu WS; Wu AJ
    Chin Med J (Engl); 1986 Sep; 99(9):721-6. PubMed ID: 2433106
    [No Abstract]   [Full Text] [Related]  

  • 5. The clinical significance of pre-operative serum CA 125 in ovarian cancer.
    Cruickshank DJ; Fullerton WT; Klopper A
    Br J Obstet Gynaecol; 1987 Jul; 94(7):692-5. PubMed ID: 2441738
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved specificity of the CA 125 enzyme immunoassay for ovarian carcinomas by use of the ratio of CA 125 to carcinoembryonic antigen.
    Wu JT; Miya T; Knight JA; Knight DP
    Clin Chem; 1988 Sep; 34(9):1853-7. PubMed ID: 2458203
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification, purification, and radioimmunoassay of NB/70K, a human ovarian tumor-associated antigen.
    Knauf S; Urbach GI
    Cancer Res; 1981 Apr; 41(4):1351-7. PubMed ID: 6163521
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tumour-associated antigen CA 125 in patients with ovarian cancer.
    Heinonen PK; Tontti K; Koivula T; Pystynen P
    Br J Obstet Gynaecol; 1985 May; 92(5):528-31. PubMed ID: 3857939
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CA-125 in patients with endometriosis.
    Barbieri RL
    Fertil Steril; 1986 Jun; 45(6):767-9. PubMed ID: 2423377
    [No Abstract]   [Full Text] [Related]  

  • 10. Tumor antigen CA 125 as a marker of ovarian epithelial carcinoma.
    Zanaboni F; Vergadoro F; Presti M; Gallotti P; Lombardi F; Bolis G
    Gynecol Oncol; 1987 Sep; 28(1):61-7. PubMed ID: 2443433
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coexpression of different antigenic markers on moieties that bear CA 125 determinants.
    Yu YH; Schlossman DM; Harrison CL; Rhinehardt-Clark A; Soper JT; Klug TL; Zurawski VR; Bast RC
    Cancer Res; 1991 Jan; 51(2):468-75. PubMed ID: 1702359
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A monoclonal antibody RIA as an antigenic determinant (CA 125) in ovarian cancer patients].
    Lian LJ
    Zhonghua Fu Chan Ke Za Zhi; 1985 Sep; 20(5):257-60, 317. PubMed ID: 2417787
    [No Abstract]   [Full Text] [Related]  

  • 13. CA-125: An evaluation.
    Nuss R; Swor MG; Benrubi MD
    J Fla Med Assoc; 1987 May; 74(5):329-32. PubMed ID: 2440975
    [No Abstract]   [Full Text] [Related]  

  • 14. Monitoring human ovarian carcinoma with a combination of CA 125, CA 19-9, and carcinoembryonic antigen.
    Bast RC; Klug TL; Schaetzl E; Lavin P; Niloff JM; Greber TF; Zurawski VR; Knapp RC
    Am J Obstet Gynecol; 1984 Jul; 149(5):553-9. PubMed ID: 6204531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Selectivity for ovarian cancer of an improved serum radioimmunoassay for human ovarian tumor-associated antigen NB/70K.
    Knauf S; Taillon-Miller P; Helmkamp BF; Bonfiglio TA; Beecham JB
    Gynecol Oncol; 1984 Mar; 17(3):349-55. PubMed ID: 6706232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preoperative evaluation of serum CA 125 levels in patients with primary epithelial ovarian cancer.
    Einhorn N; Bast RC; Knapp RC; Tjernberg B; Zurawski VR
    Obstet Gynecol; 1986 Mar; 67(3):414-6. PubMed ID: 2418395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Serum CA 125 levels in a group of nonhospitalized women: relevance for the early detection of ovarian cancer.
    Zurawski VR; Broderick SF; Pickens P; Knapp RC; Bast RC
    Obstet Gynecol; 1987 Apr; 69(4):606-11. PubMed ID: 2434895
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical evaluation of ovarian tumor antigen NB/70K: monoclonal antibody assays for distinguishing ovarian cancer from other gynecologic disease.
    Knauf S
    Am J Obstet Gynecol; 1988 May; 158(5):1067-72. PubMed ID: 3369485
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Monoclonal antibodies in the radioimmunological diagnosis of malignant tumors of the gastrointestinal tract and ovaries].
    Tkacheva GA; Blokhina NG; Klimenkov AA; Kozachenko VP
    Vopr Onkol; 1985; 31(5):36-42. PubMed ID: 2409674
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Circulating DF3 and CA125 antigen levels in serum from patients with epithelial ovarian carcinoma.
    Sekine H; Hayes DF; Ohno T; Keefe KA; Schaetzl E; Bast RC; Knapp R; Kufe DW
    J Clin Oncol; 1985 Oct; 3(10):1355-63. PubMed ID: 2413181
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.